Abstract:Highlights • CBD shapes the tumor microenvironment to prevent tumor progression. • CBD-induced metabolic reprogramming inhibits alternative activation of macrophage. • CBD inhibits PI3K-Akt signaling to downregulate anti-inflammatory gene expression. • CBD enhances the response to anti-PD-1 immunotherapy. Colorectal tumors often create an immunosuppressive microenvironment that prevents them from responding to immunotherapy. Cannabidiol (CBD) is a non-psychoactive natural active ingredient from the cannabis plant that has various pharmacological effects, including neuroprotective, antiemetic, anti-inflammatory, and antineoplastic activities. This study aimed to elucidate the specific anticancer mechanism of CBD by single-cell RNA sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq) technologies. Here, we report that CBD inhibits colorectal cancer progression by modulating the suppressive tumor microenvironment (TME). Our single-cell transcriptome and ATAC sequencing results showed that CBD suppressed M2-like macrophages and promoted M1-like macrophages in tumors both in strength and quantity. Furthermore, CBD significantly enhanced the interaction between M1-like macrophages and tumor cells and restored the intrinsic anti-tumor properties of macrophages, thereby preventing tumor progression. Mechanistically, CBD altered the metabolic pattern of macrophages and related anti-tumor signaling pathways. We found that CBD inhibited the alternative activation of macrophages and shifted the metabolic process from oxidative phosphorylation and fatty acid oxidation to glycolysis by inhibiting the PI3K-Akt signaling pathway and related downstream target genes. Furthermore, CBD-mediated macrophage plasticity enhanced the response to anti-PD-1 immunotherapy in xenografted mice. Taken together, we provide new insights into the anti-tumor effects of CBD. Graphical abstract Graphic illustration of the anti-tumor mechanism of CBD in colon cancer. The tumor microenvironment (TME) of all cell types in mouse MC38 xenograft tumors after cannabidiol (CBD) treatment was investigated by single-cell transcriptome sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq). CBD inhibits the alternative activation of macrophages and shifts the metabolic process from oxidative phosphorylation and fatty acid oxidation to glycolysis by inhibiting the PI3K-Akt signaling pathway and related downstream target genes, which relieves the inhibitory immune microenvironment and restores the intrinsic antitumor effects of macrophages. Furthermore, CBD-mediated macrophage plasticity enhances the response to anti-PD-1 immunotherapy in xenografted mice. Download : Download high-res image (340KB) Download : Download full-size image

Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway

Anti-proliferative Effect of Cannabidiol in Prostate Cancer Cell PC3 is Mediated by Apoptotic Cell Death, NFκB Activation, Increased Oxidative Stress, and Lower Reduced Glutathione Status

Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1.

Inhibition of P21 Activated Kinase Enhances Tumour Immune Response and Sensitizes Pancreatic Cancer to Gemcitabine

Anti-proliferative and apoptotic effect of cannabinoids on human pancreatic ductal adenocarcinoma xenograft in BALB/c nude mice model

Cannabidiol's cytotoxicity in pancreatic cancer is induced via an upregulation of ceramide synthase 1 and ER stress

p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation

Inhibition Of Group 1 P21-Activated Kinases Suppresses Pancreatic Stellate Cell Activation And Increases Survival Of Mice With Pancreatic Cancer

PAK Inhibition by PF-3758309 Enhanced the Sensitivity of Multiple Chemotherapeutic Reagents in Patient-Derived Pancreatic Cancer Cell Lines.

Pan-KRAS inhibitors suppress proliferation through feedback regulation in pancreatic ductal adenocarcinoma

Single-cell analyses reveal cannabidiol rewires tumor microenvironment via inhibiting alternative activation of macrophage and synergizes with anti-PD-1 in colon cancer

Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer

Propionyl-CoA carboxylase subunit B regulates anti-tumor T cells in a pancreatic cancer mouse model

Cannabinoids decrease intestinal permeability and induce colonic CD103+ dendritic cells to increase T regulatory cells leading to decreased murine colitis-associated colon cancer

PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer

A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway

Effects of VCP979 Novel P38 Mitogen Activated Protein Kinase Inhibitor on Progression of Pancreatic Cancer in Mouse Model with Diabetic Conditions

Cannabidiol exhibits potent anti-cancer activity against gemcitabine-resistant cholangiocarcinoma via ER-stress induction in vitro and in vivo

A Nanodrug Simultaneously Inhibits Pancreatic Stellate Cell Activation and Regulatory T Cell Infiltration to Promote the Immunotherapy of Pancreatic Cancer.

Abstract 6532: Blockade of CD24 sensitizes pancreatic cancer to Kras inhibitors

Cannabidiol Possibly Improves Survival of Patients with Pancreatic Cancer: A Case Series